Related Experiment Video
Updated: May 13, 2026
07:52
Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation
Published on: June 17, 2013
39.9K
The Impact of Transcranial Direct Current Stimulation on Drug-Resistant Temporal Lobe Epilepsy
Omar El-Nakah1, Ann Ali AbdelKader2, Nirmeen A Kishk2
1Medical Physiology Department, Medical Research & Clinical Studies Institute, National Research Centre, Giza, Egypt.
Summary
Cathodal transcranial direct current stimulation (c-tDCS) significantly reduced seizure frequency and severity in patients with drug-resistant epilepsy. This neuromodulation technique also decreased epileptiform discharges on EEG for up to one month.
Area of Science:
- Neurology
- Neuroscience
- Medical Devices
Background:
- Drug-resistant epilepsy presents a significant clinical challenge.
- Noninvasive neuromodulation techniques offer potential therapeutic strategies.
- Cathodal transcranial direct current stimulation (c-tDCS) is known to reduce cortical excitability.
Purpose of the Study:
- To evaluate the efficacy of c-tDCS in managing drug-resistant temporal lobe epilepsy.
- To assess the impact of c-tDCS on seizure frequency and severity.
- To investigate changes in electroencephalography (EEG) findings following c-tDCS treatment.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involving 30 patients with drug-resistant temporal lobe epilepsy.
- Participants were assigned to either active c-tDCS or sham sessions over five consecutive days.
- Stimulation was applied over the presumed seizure onset zone or areas of high interictal discharge frequency.
Main Results:
- A statistically significant decrease in seizure frequency was observed in the c-tDCS group.
- The Liverpool Seizure Severity Scale scores improved significantly post-treatment.
- Reductions in epileptiform discharges were noted on EEG recordings one month after the intervention.
Conclusions:
- c-tDCS demonstrates efficacy in improving seizure control for patients with drug-resistant temporal lobe epilepsy.
- The benefits of c-tDCS, including reduced seizure frequency and severity, persisted for up to one month.
- These findings support previous research on the therapeutic potential of c-tDCS in epilepsy management.
Keywords:
Drug-resistant epilepsyLiverpool Seizure Severity ScaleSeizure severityTemporal lobeTranscranial direct current stimulationMore Related Videos
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:14Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...